Detalles de la búsqueda
1.
Lower Risk of Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) with the Delta variant of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272267
2.
Cross-Sectional Study of University students attitudes to on campus delivery of COVID-19 vaccines and future-proofing MenACWY and MMR vaccination rates by adopting COVID-19 vaccine roll-out strategies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270394
3.
Asymptomatic SARS-CoV-2 infection by age: A systematic review and meta-analysis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22274697
4.
Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267713
5.
Risk of SARS-CoV-2 reinfections in children: prospective national surveillance, January 2020 to July 2021, England
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21267372
6.
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263583
7.
Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: The CLoCk Study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22273117
8.
Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22271126
9.
Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21264964
10.
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22277838
11.
Seroprevalence of SARS-CoV-2 antibodies in children - A prospective multicentre cohort study.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20183095
12.
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20105460
13.
Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20108126
14.
Primary Omicron infection elicits weak antibody response but robust cellularimmunity in children
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-501570
15.
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-362319
16.
Serological surveillance of SARS-CoV-2: trends and humoral response in a cohort of public health workers
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20216689
17.
Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20153320
18.
Comparison of children and young people admitted with SARS-CoV-2 across the UK in the first and second pandemic waves: prospective multicentre observational cohort study
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263567
19.
Children develop strong and sustained cross-reactive immune responses against spike protein following SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21255275
Resultados
1 -
19
de 19
1
Próxima >
>>